Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $25.2200 (7.11%) ($25.2200 - $25.2550) on Fri. Sep. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.18% (three month average) | RSI | 59 | Latest Price | $25.2200(7.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) XBI(41%) IWO(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.59% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) TBT(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.59% (StdDev 3.18%) | Hourly BBV | 2.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $23.37(7.92%) | 10 Day Moving Average | $23.64(6.68%) | 20 Day Moving Average | $23.48(7.41%) | To recent high | -6.6% | To recent low | 22.9% | Market Cap | $3.693b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |